The serpin proteinase inhibitor 8: An endogenous furin inhibitor released from human platelets
暂无分享,去创建一个
W. Kisiel | C. Dubois | M. Laprise | Walter Kisiel | Francine Grondin | Claire M Dubois | Julie Leblond | Marie-Hélène Laprise | Simon Gaudreau | F. Grondin | Julie Leblond | S. Gaudreau
[1] R. Leduc,et al. Characterization of a secreted form of human furin endoprotease. , 1993, Biochemical and biophysical research communications.
[2] Carlos F. Barbas,et al. Purification of Storage Granule Protein-23 , 1996, The Journal of Biological Chemistry.
[3] F. Dorner,et al. Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease. , 1999 .
[4] R. Day,et al. Inhibitors of the subtilase-like pro-protein convertases (SPCs). , 2002, Current pharmaceutical design.
[5] C. Dubois,et al. Furin gene (fur) regulation in differentiating human megakaryoblastic Dami cells: involvement of the proximal GATA recognition motif in the P1 promoter and impact on the maturation of furin substrates. , 2002, Blood.
[6] A. V. D. van den Ouweland,et al. Development and characterization of a panel of monoclonal antibodies against the novel subtilisin-like proprotein processing enzyme furin. , 1992, Hybridoma.
[7] R. Nachman,et al. Platelet alpha2-macroglobulin and alpha1-antitrypsin. , 1976, The Journal of biological chemistry.
[8] G. Thomas,et al. Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.
[9] W. Kisiel,et al. Molecular Cloning, Expression, and Partial Characterization of Two Novel Members of the Ovalbumin Family of Serine Proteinase Inhibitors (*) , 1995, The Journal of Biological Chemistry.
[10] A. Johnsen,et al. Naturally occurring Arg(-1) to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C. , 1997, Blood.
[11] A. Imbriano. [Blood coagulation]. , 1955, La Semana medica.
[12] O. Egeberg. Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.
[13] M. Pfleiderer,et al. Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro. , 2000, Thrombosis research.
[14] P. Sims,et al. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. , 1993, The Journal of biological chemistry.
[15] A. Strauss,et al. Rat factor X is synthesized as a single chain precursor inducible by prothrombin fragments. , 1982, The Journal of biological chemistry.
[16] M. Richer,et al. The Spn4 gene of Drosophila encodes a potent furin-directed secretory pathway serpin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Leduc,et al. Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*) , 1995, The Journal of Biological Chemistry.
[18] F. Dorner,et al. 'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus. , 2001, The Biochemical journal.
[19] J. Potempa,et al. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.
[20] L. Gombau,et al. Processing of type 1 plasminogen activator inhibitor (PAI-1) into the regulated secretory pathway. , 1994, The Journal of biological chemistry.
[21] Raymond,et al. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. , 1989, The Journal of clinical investigation.
[22] B. Bennett,et al. Fibrinolysis and thrombosis. , 1994, Bailliere's clinical haematology.
[23] A. Michelson,et al. Effect of Strenuous Exercise on Platelet Activation State and Reactivit , 1993, Circulation.
[24] I. Juhan-vague,et al. Detection of Plasminogen Activator Inhibitor-1 (PAI-1) mRNA in Human Megakaryocytes by In Situ Hybridization , 1994, Thrombosis and Haemostasis.
[25] W. Kisiel,et al. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues. , 1998, Biochemical and biophysical research communications.
[26] W. Kisiel,et al. Distribution of the Human Intracellular Serpin Protease Inhibitor 8 in Human Tissues , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[27] B. Furie,et al. Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Brake,et al. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Plow,et al. The presence and release of alpha 2-antiplasmin from human platelets. , 1981, Blood.
[30] S. Khuri,et al. The effects of aspirin and hypothermia on platelet function in vivo , 1999, British journal of haematology.
[31] R. Leduc,et al. Serpin‐like properties of α1‐antitrypsin Portland towards furin convertase , 1998 .
[32] P. Gettins,et al. The Mechanism by Which Serpins Inhibit Thrombin and Other Serine Proteinases a , 1994, Annals of the New York Academy of Sciences.
[33] J. Whisstock,et al. The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.
[34] A. Rehemtulla,et al. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. , 1992, Blood.
[35] D. Lawrence,et al. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. , 1994, The Journal of biological chemistry.
[36] G. Thomas,et al. alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Belin,et al. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. , 1989, The EMBO journal.
[38] R. Schleef,et al. Protease inhibitor 10 inhibits tumor necrosis factor alpha -induced cell death. Evidence for the formation of intracellular high M(r) protease inhibitor 10-containing complexes. , 2000, The Journal of biological chemistry.
[39] A. Ludlow,et al. Latent TGF‐β1 activation by platelets , 2004 .
[40] C. Dubois,et al. Enhanced TGFbeta1 maturation in high five cells coinfected with recombinant baculovirus encoding the convertase furin/pace: improved technology for the production of recombinant proproteins in insect cells. , 1998, Biotechnology and bioengineering.
[41] Kisiel,et al. Expression, Purification, and Inhibitory Properties of Human Proteinase Inhibitor 8 , 1997, Biochemistry.
[42] B. Bahnak,et al. Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. , 1984, Blood.
[43] R. Leduc,et al. Serpin-like properties of alpha1-antitrypsin Portland towards furin convertase. , 1998, FEBS letters.
[44] K. Mann,et al. Surface-dependent hemostasis. , 1992, Seminars in hematology.
[45] W. Kisiel,et al. Inhibition of Soluble Recombinant Furin by Human Proteinase Inhibitor 8* , 1998, The Journal of Biological Chemistry.
[46] R. Leduc,et al. Ectodomain shedding of furin: kinetics and role of the cysteine‐rich region , 2002, FEBS letters.
[47] R. Carrell,et al. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. , 1989, Biochemistry.
[48] T. Watanabe,et al. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. , 1991, The Journal of biological chemistry.
[49] H. Klenk,et al. Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation , 1994, The Journal of cell biology.